Ros J. Cutts

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

ctDNA monitoring using tumor-informed copy number analysis.

ctDNA monitoring using tumor-informed copy number analysis.

Journal: EMBO molecular medicine

Published: August 05, 2025

Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.

Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study.

Journal: Cancers

Published: February 18, 2023

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.

Journal: The Lancet. Oncology

Published: April 24, 2020

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.

Journal: Nature communications

Published: July 18, 2019

Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.

Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.

Journal: British journal of cancer

Published: May 23, 2018

Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.

Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 22, 2017

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer.

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 07, 2017

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

Journal: Cancer discovery

Published: October 19, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026